CORBF (Global Cord Blood) Net Margin %: 35.23% (As of Mar. 2022)


CORBF Global Cord Blood Corp CORBF
12 GF Score
Price $0.95
View Full Analysis

What is Global Cord Blood Net Margin %?

Global Cord Blood CORBF 12 Net Margin % is 35.23% as of Mar. 2022. GuruFocus rates CORBF with a GF Score™ of 12/100.

Net margin is calculated as Net Income divided by its Revenue. Global Cord Blood's Net Income for the three months ended in Mar. 2022 was $16.5 Mil. Global Cord Blood's Revenue for the three months ended in Mar. 2022 was $46.8 Mil. Therefore, Global Cord Blood's net margin for the quarter that ended in Mar. 2022 was 35.23%.

The historical rank and industry rank for Global Cord Blood's Net Margin % or its related term are showing as below:


CORBF's Net Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -2.405
* Ranked among companies with meaningful Net Margin % only.

Global Cord Blood  (OTCPK:CORBF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Global Cord Blood Net Margin % Related Terms

Global Cord Blood Net Margin % Historical Data

* Premium members only.

The historical data trend for Global Cord Blood's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Cord Blood Net Margin % Chart

Global Cord Blood Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.31 29.50 38.54 43.83 40.30

Global Cord Blood Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.25 43.28 40.09 42.31 35.23

CORBF vs PRE, LMDX, NOTV: Net Margin % Comparison

For the Diagnostics & Research subindustry, Global Cord Blood's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Global Cord Blood Net Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Global Cord Blood's Net Margin % distribution charts can be found below:

* The bar in red indicates where Global Cord Blood's Net Margin % falls into.


CORBF
12GF Score
Global Cord Blood Corp CORBF
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Cord Blood Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Global Cord Blood's Net Margin for the fiscal year that ended in Mar. 2022 is calculated as

Net Margin=Net Income (A: Mar. 2022 )/Revenue (A: Mar. 2022 )
=78.975/195.955
=40.30 %

Global Cord Blood's Net Margin for the quarter that ended in Mar. 2022 is calculated as

Net Margin=Net Income (Q: Mar. 2022 )/Revenue (Q: Mar. 2022 )
=16.505/46.844
=35.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 35.23% mean?
Global Cord Blood (CORBF) has a Net Margin % of 35.23% as of Mar. 2022. Net margin is the ratio of total net income to net sales. View historical data on Global Cord Blood and its competitors.
Is Global Cord Blood's Net Margin % too high?
Global Cord Blood's current Net Margin % is 35.23%. Overall, Global Cord Blood has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Global Cord Blood's Net Margin % compare to PRE and LMDX?
Global Cord Blood's Net Margin % of 35.23% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Global Cord Blood and its competitors. Global Cord Blood's current Net Margin % is 35.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Cord Blood stock overvalued right now?
Global Cord Blood (CORBF) has a current Net Margin % of 35.23%. The current Net Margin % is 35.23%. Global Cord Blood's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Global Cord Blood (CORBF), the current Net Margin % is 35.23% as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Global Cord Blood Business Description

Address 1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants. The company generates all of its revenues by providing subscribers with processing services, which consist of the testing and processing of cord blood units, and storage services, which consist of the storage of cord blood units in its facilities.
12GF Score

Get the complete analysis for CORBF

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95
Price